Board of Directors

The company´s seven-member Board of Directors draws upon in-depth, diverse experience in health care, the pharmaceutical industry and management.

John M. Siebert, Ph.D.
Chairman and Chief Executive Officer, CyDex Pharmaceuticals, Inc.

Steven D. Cosler 
Consultant

James C. Gale 
Managing Director, Sanders Morris Harris

Elliot F. Hahn, Ph.D. 
President, SoLapharm

David E. Poltack 
General Partner, TVM Capital

Philip L. Smith, Ph.D. 
General Partner, SR One